The company is a medical devices company that has developed an innovative implantable apparatus for the treatment of heart failure. Heart failure is characterized by a gradual weakening of the heart that leads to a loss of contractile function, marked by decrease in delivery of oxygenated blood to the body resulting in shortness of breath, dizziness, low blood pressure and short life expectancy. The company’s product serves as a heart assistance device that helps pump blood without contacting it. The product is implanted in a minimally invasive manner on the heart’s outflow tract, and pulsates to add force to the blood being pumped out of the heart thereby intensifying the work done by the heart. The company’s product is indicated for even the most critical forms of heart failure, including end-stage heart failure that requires heart transplant or heart-replacement pumps. Currently there are over 1.5 million patients in the US suffering from critical heart failure.